Faster global financial news!
RedHill Biopharma
-
RedHill Biopharma (RDHL) acquires commercialization rights for Rebyota and Clenpiq for $12 million upfront, with the two products' combined sales reaching $37.5 million in 2025.
The transaction involves the global exclusive commercialization rights for Rebyota and the US exclusive commercialization rights for Clenpiq, sold by Ferring Pharmaceuticals. The agreement has an init
-
RedHill Biopharma (RDHL) acquires commercialization rights for Rebyota and Clenpiq for $12 million upfront, with the two products' combined sales reaching $37.5 million in 2025.
The transaction involves the global exclusive commercialization rights for Rebyota and the US exclusive commercialization rights for Clenpiq, sold by Ferring Pharmaceuticals. The agreement has an init
- No data
RedHill Biopharma
24H Trending
-
1
NVS Coin: Project Status, Trading Channels, and High-Risk Warning
-
2
What is Fantom (FTM)? FTM Token Analysis and Future Outlook
-
3
BMP Token Analysis: Cryptocurrency with Multiple Identities and Investment Considerations
-
4
What is ELCASH Coin? Electric Cash Token Analysis and Trading Channels
-
5
NUKE Coin: A Multifaceted Analysis of Homonymous Tokens in the Robinhood Ecosystem, Gaming, and Payment Solutions
-
6
FER Token: A Guide to Trading and Acquiring Ferro Protocol's Native Token
-
7
Key Differences Between US and A-Share Markets: A Five-Core Mechanism Analysis
-
8
Filecoin (FIL) Price Potential Analysis: Influencing Factors and Market Outlook
-
9
WAHED Coin Analysis: Project Vision, Technology, and Trading Status
-
10
Trump Coin (TRUMP) Future Trend Analysis: Influencing Factors and Market Outlook
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
